Cohen Klingenstein LLC Reduces Position in Solventum Co. (NYSE:SOLV)

Cohen Klingenstein LLC decreased its position in shares of Solventum Co. (NYSE:SOLV) by 12.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,869 shares of the company’s stock after selling 1,085 shares during the period. Cohen Klingenstein LLC’s holdings in Solventum were worth $520,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of SOLV. Victory Capital Management Inc. purchased a new stake in shares of Solventum during the second quarter valued at $1,194,000. Texas Permanent School Fund Corp acquired a new stake in shares of Solventum during the second quarter worth $1,187,000. American Century Companies Inc. purchased a new stake in Solventum during the 2nd quarter valued at about $6,699,000. DekaBank Deutsche Girozentrale acquired a new position in Solventum in the 2nd quarter worth approximately $1,032,000. Finally, Oppenheimer Asset Management Inc. acquired a new position in shares of Solventum in the 2nd quarter valued at about $318,000.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on SOLV. Wolfe Research started coverage on Solventum in a research report on Thursday, September 26th. They issued a “peer perform” rating on the stock. Stifel Nicolaus began coverage on shares of Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price target on the stock. Morgan Stanley lifted their target price on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Piper Sandler boosted their price target on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Finally, Mizuho initiated coverage on Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. One analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $68.29.

Solventum Stock Up 1.2 %

Shares of NYSE:SOLV opened at $73.60 on Friday. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The company’s 50-day moving average price is $69.09 and its 200 day moving average price is $65.34. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.